Journal of Pharmacology and Pharmacotherapeutics
Volume 12, Issue 1
2021 · pp. 1–28 · 6 articles
- Volume
- 12
- Issue
- 1
- Published
- 2021
- Pages
- 1–28
- Articles
- 6
- Sections
- 4
- ISSN
- Print - 0976-500X, Online - 0976-5018
- Journal
- JPP
In this issue
Research Paper
- Article
Omaimah Toufiq, Syed Wasif Gillani, Farhanah Mohamed, Nafis Pasha, Muhsina Chiraparambil, Affana Parveen
pp. 1–9 · DOI: 10.4103/jpp.JPP_154_20 · 2021
Objective: To compare the safety and efficacy of linagliptin with pioglitazone in combination therapy of metformin for the management of type 2 diabetes mellitus (T2DM). Materials and Methods: A meta‑analayis research de…
- Article
Sonali Opneja, Shirley Ann D Souza, Roopesh Sureshan, Pabitra Ghoshal
pp. 10–13 · DOI: 10.4103/jpp.JPP_163_20 · 2021
Objective: To compare the efficacy and side effects of 5HT3 antagonists, ramosetron, and ondansetron as prophylaxis for postoperative nausea and vomiting (PONV) following general anesthesia. Materials and Methods: One hu…
- Article
Aarya Jitendra Kshirsagar, Yogita Karandikar, Leena Phadake
pp. 14–19 · DOI: 10.4103/jpp.JPP_166_20 · 2021
Objective: To observe the effect of statins on cardiac autonomic neuropathy in patients with diabetes and to study the correlation between cardiac autonomic neuropathy as assessed by cardiac autonomic reflex tests (CARTs…
Research Letter
- Article
Sharan Shyam, Sanjay Jaiswal
pp. 20–22 · DOI: 10.4103/jpp.JPP_156_20 · 2021
Case Report
- Article
Nidheesh Chooriyil, Doyce Jom, Prabitha Panattil, Syam Sreedharan
pp. 23–25 · DOI: 10.4103/jpp.JPP_157_20 · 2021
Protamine is a routinely used safe antidote for heparin reversal in cardiovascular surgeries. Protamine was first introduced to prolong the action of insulin preparations. As protamine interacts with platelets and fibrin…
Review Article
- Review
Merin Babu, Keechilat Pavithran
pp. 26–28 · DOI: 10.4103/jpp.jpp_170_20 · 2021
Androgen deprivation therapy (ADT) is currently the mainstay of treatment for advanced prostate cancer. The peptide formulations of gonadotropin‑releasing hormone (GnRH) antagonists need to be given subcutaneously every …

